Improving Labor Management for Patients With Severe Obesity Using Abdominal Pannus Retraction
NCT07924800, Not applicable, Not yet recruiting, Medical College of Wisconsin
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Improving Labor Management for Patients With Severe Obesity Using Abdominal Pannus Retraction | ClinicalTrials.gov |
| NCT number | NCT07924800 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 100 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Medical College of Wisconsin | ClinicalTrials.gov |
| Conditions | Birth Length, Severe Obesity | ClinicalTrials.gov |
| Interventions | Abdominal Pannus Retraction | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Time from randomization to delivery | From randomization at the start of labor through delivery (typically within 48 hours after randomization | ClinicalTrials.gov | |
| Secondary | Time from randomization to complete cervical dilation | From randomization to the first documentation of complete cervical dilation (10 cm), assessed for up to approximately 48 hours after randomization. | ClinicalTrials.gov | |
| Secondary | Duration of the second stage of labor | From complete cervical dilation (10 cm) to birth, assessed for up to approximately 12 hours after complete dilation. | ClinicalTrials.gov | |
| Secondary | Mode of delivery | At delivery | Will capture if delivery resulted in a vaginal birth or a cesarean section | ClinicalTrials.gov |
| Secondary | Oxytocin utilization | From labor until birth. | Collect data of Oxytocin (Pitocin) as a labor augmentation agent | ClinicalTrials.gov |
| Secondary | Number of individuals with at least one composite postpartum hemorrhage morbidity | From birth through 72 hours after birth | Birthing people who experience one or more of the following events will be counted once, regardless of the number of events experienced: Estimated blood loss \>1000 milliliters (mL), adminsitration of uterotonics, transexamic acid, blood transfusion, or surgical interventions (dilation and curettage, Bakri, Jadha, laparotomy, interventional radiology) | ClinicalTrials.gov |
| Secondary | Number of birthing people with at least one maternal complications | From birth through 72 hours after birth | Number maternal complicaitons defined as counts for wound infection, endometritis, and thromboembolism. | ClinicalTrials.gov |
| Secondary | Number of neonates with at least one composite neonatal morbidity | From birth through 72 hours after birth | Neonates who experience one or more of the following events will be counted once, regardless of the number of events experienced: NICU admission, seizures, hypoxic-ischemic encephalopathy, intracranial hemorrhage, electrolyte abnormalities, hypoglycemia, hyperbilirubinemia, hypothermia, hyperthermia, sepsis, and antibiotic administration | ClinicalTrials.gov |
| Secondary | Patient satisfaction measured by Childbirth Experience Questionaire (CEQ2) | Once after birth, within 48 hours of delivery. | Childbirth experience will be assessed using the Childbirth Experience Questionnaire version 2.0 (CEQ 2.0), a 25-item questionnaire covering four domains: own capacity, professional support, perceived safety, and participation. Participants will complete the questionnaire after birth prior to discharge from th ehopsitals. The total score is calculated as the mean score across the questionnaire items and ranges from 1 to 4. Higher scores indicate a more positive childbirth experience. | ClinicalTrials.gov |
| Secondary | Provider-rated acceptability of abdominal pannus retraction on the Acceptability of Intervention Measure (AIM) | Once within 24 hours after the participant's delivery. | Acceptability of standardized Panni XL abdominal pannus retraction during labor will be assessed among nursing and obstetric providers using the four-item Acceptability of Intervention Measure (AIM). The mean of the four item responses will be calculated, with scores ranging from 1 to 5. Higher scores indicate greater acceptability. | ClinicalTrials.gov |
| Secondary | Provider-rated appropriateness of abdominal pannus retraction on the Intervention Appropriateness Measure (IAM) | Once within 24 after the participant's delivery. | Perceived appropriateness of standardized Panni XL abdominal pannus retraction during labor will be assessed among nursing and obstetric providers using the four-item Intervention Appropriateness Measure (IAM). The mean of the four item responses will be calculated, with scores ranging from 1 to 5. Higher scores indicate greater perceived appropriateness. | ClinicalTrials.gov |
| Secondary | Provider-rated feasibility of abdominal pannus retraction on the Feasibility of Intervention Measure (FIM) | Once within 24 after the participant's delivery. | Perceived feasibility of standardized Panni XL abdominal pannus retraction during labor will be assessed among nursing and obstetric providers using the four-item Feasibility of Intervention Measure (FIM). The mean of the four item responses will be calculated, with scores ranging from 1 to 5. Higher scores indicate greater perceived feasibility. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)